MOG antigen recall assay

TR Tommy Regen
SI Sandrine Isaac
AA Ana Amorim
NN Nicolás Gonzalo Núñez
JH Judith Hauptmann
AS Arthi Shanmugavadivu
MK Matthias Klein
RS Roman Sankowski
IM Ilgiz A. Mufazalov
NY Nir Yogev
JH Jula Huppert
FW Florian Wanke
MW Michael Witting
AG Alexandra Grill
EG Eric J. C. Gálvez
AN Alexei Nikolaev
MB Michaela Blanfeld
IP Immo Prinz
PS Philippe Schmitt-Kopplin
TS Till Strowig
CR Christoph Reinhardt
MP Marco Prinz
TB Tobias Bopp
BB Burkhard Becher
CU Carles Ubeda
AW Ari Waisman
request Request a Protocol
ask Ask a question
Favorite

For T cell priming analysis, the spleens and inguinal lymph nodes of immunized mice were removed 10 days after immunization, and single-cell suspensions were prepared. For peak EAE analysis, mice were transcardially perfused with 0.9% NaCl solution, and the spinal cords were removed and digested with collagenase II (Thermo Fisher Scientific) and DNase I (Roche), before being separated on 30/37/70% Percoll gradient. Single-cell suspensions of all organs were in vitro cultured in the presence of MOG peptide (20 μg/ml). After 2 hours, cultures were supplemented with brefeldin A (1 μg/ml; Merck) to block the secretion of cytokines. After additional 4 hours of culture, cells were harvested and stained for flow cytometry analysis. T cell expression of CD154 was assessed as marker for recent activation, thereby serving as surrogate marker for MOG antigen specificity. CD154high T cells were then further analyzed for cytokine expression.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A